Annual Shareholders Equity
$423.44 M
-$4.54 M-1.06%
December 31, 2024
Summary
- As of March 13, 2025, BHVN annual stockholders equity is $423.44 million, with the most recent change of -$4.54 million (-1.06%) on December 31, 2024.
- During the last 3 years, BHVN annual shareholders equity has risen by +$388.75 million (+1120.59%).
- BHVN annual shareholders equity is now -21.41% below its all-time high of $538.77 million, reached on December 31, 2022.
Performance
BHVN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$423.44 M
+$107.43 M+34.00%
December 31, 2024
Summary
- As of March 13, 2025, BHVN quarterly stockholders equity is $423.44 million, with the most recent change of +$107.43 million (+34.00%) on December 31, 2024.
- Over the past year, BHVN quarterly shareholders equity has dropped by -$4.54 million (-1.06%).
- BHVN quarterly shareholders equity is now -21.41% below its all-time high of $538.77 million, reached on December 31, 2022.
Performance
BHVN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
BHVN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.1% | -1.1% |
| 3 y3 years | +1120.6% | -21.4% |
| 5 y5 years | +5803.6% | -21.4% |
BHVN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.4% | +1120.6% | -21.4% | +322.5% |
| 5 y | 5-year | -21.4% | +5803.6% | -21.4% | +208.5% |
| alltime | all time | -21.4% | +1040.3% | -21.4% | +208.5% |
Biohaven Pharmaceutical Holding Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $423.44 M(-1.1%) | $423.44 M(+34.0%) |
| Sep 2024 | - | $316.01 M(-17.7%) |
| Jun 2024 | - | $383.74 M(+27.3%) |
| Mar 2024 | - | $301.45 M(-29.6%) |
| Dec 2023 | $427.98 M(-20.6%) | $427.98 M(+47.6%) |
| Sep 2023 | - | $290.01 M(-25.1%) |
| Jun 2023 | - | $387.25 M(-18.0%) |
| Mar 2023 | - | $472.26 M(-12.3%) |
| Dec 2022 | $538.77 M(+1453.1%) | $538.77 M(+437.6%) |
| Sep 2022 | - | $100.22 M(-61.8%) |
| Jun 2022 | - | $262.23 M(+655.9%) |
| Dec 2021 | $34.69 M(+106.7%) | - |
| Dec 2021 | - | $34.69 M(-108.9%) |
| Dec 2020 | $16.78 M(-326.0%) | - |
| Dec 2020 | - | -$390.37 M(+83.8%) |
| Sep 2020 | - | -$212.38 M(+498.8%) |
| Jun 2020 | - | -$35.47 M(-129.1%) |
| Mar 2020 | - | $121.96 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -$7.42 M(-104.9%) | - |
| Dec 2019 | - | -$7.42 M(-106.2%) |
| Sep 2019 | - | $118.98 M(-36.3%) |
| Jun 2019 | - | $186.74 M(+92.5%) |
| Mar 2019 | - | $97.01 M(-35.7%) |
| Dec 2018 | $150.92 M(+14.4%) | - |
| Dec 2018 | - | $150.92 M(+129.3%) |
| Sep 2018 | - | $65.81 M(-44.6%) |
| Jun 2018 | - | $118.83 M(+10.2%) |
| Mar 2018 | - | $107.82 M(-18.3%) |
| Dec 2017 | $131.97 M(-393.1%) | - |
| Dec 2017 | - | $131.97 M(-15.5%) |
| Sep 2017 | - | $156.19 M(-19.0%) |
| Jun 2017 | - | $192.85 M(-460.2%) |
| Mar 2017 | - | -$53.54 M(+18.9%) |
| Dec 2016 | -$45.03 M(-4036.5%) | - |
| Dec 2016 | - | -$45.03 M |
| Dec 2015 | $1.14 M | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual stockholders equity?
- What is the all time high annual shareholders equity for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual shareholders equity year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly shareholders equity year-on-year change?
What is Biohaven Pharmaceutical Holding annual stockholders equity?
The current annual shareholders equity of BHVN is $423.44 M
What is the all time high annual shareholders equity for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual stockholders equity is $538.77 M
What is Biohaven Pharmaceutical Holding annual shareholders equity year-on-year change?
Over the past year, BHVN annual stockholders equity has changed by -$4.54 M (-1.06%)
What is Biohaven Pharmaceutical Holding quarterly stockholders equity?
The current quarterly shareholders equity of BHVN is $423.44 M
What is the all time high quarterly shareholders equity for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly stockholders equity is $538.77 M
What is Biohaven Pharmaceutical Holding quarterly shareholders equity year-on-year change?
Over the past year, BHVN quarterly stockholders equity has changed by -$4.54 M (-1.06%)